Product Information
Cymbalta in MDD
Multidimensional Aspects of Depression
Major depressive disorder (MDD) has a broad range of symptoms, including depressed mood, loss of energy, feelings of guilt, lack of energy, decreased concentration, changes in appetite, sleep or psychomotor activity, and recurrent thoughts of death or suicidality. Other associated symptoms may also include anxiety or phobias, bodily aches and pains, and irritability.1 Treating MDD can be complex. Patients may present with emotional and somatic symptoms.
Cymbalta Demonstrated Broad Efficacy, Safety and Tolerability, and Once-daily Dosing in MDD
- Broad efficacy: Cymbalta demonstrated high remission rates, rapid relief from core emotional symptoms,relief from associated painful somatic symptoms, and reduced risk of relapse over 6 months for patients with MDD2,3,4
- Safety and tolerability: Learn about treatment-emergent adverse events associated with Cymbalta in MDD5
- Simplicity: Cymbalta is taken once daily and offers convenience and ease of use5
References:
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC: American Psychiatric Association, 2000.
- Perahia DG, et al. Br J Psychiatry. 2006;188:346-353.
- Data on file, Lilly Research Laboratories: CYM20060101A.
- Fava M, et al. J Clin Psychiatry. 2004;65(4):521-530.
- Cymbalta full Prescribing Information, 2008.
Cymbalta for Fibromyalgia
Cymbalta is indicated for the management of fibromyalgia.
Formulary Access Finder
Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.
Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.
Thought Leader Podcasts
Listen to peers and experts discuss the latest advances in diagnosis and treatment for MDD, GAD, DPNP, and fibromyalgia.
Listen to the podcasts now.







